메뉴 건너뛰기




Volumn 48, Issue 10, 2007, Pages 1968-1975

Autologous stem cell transplantation for patients with active Hodgkin's lymphoma: Long-term outcome of 61 patients from a single institution

Author keywords

Autologous stem cell transplantation; Hodgkin's lymphoma; Prognostic factors

Indexed keywords

BLEOMYCIN; CARMUSTINE; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; GALLIUM 67; MELPHALAN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

EID: 35148893207     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701573265     Document Type: Article
Times cited : (8)

References (24)
  • 1
    • 33645299075 scopus 로고    scopus 로고
    • Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Definitions and current practice in Europe
    • Ljungman, P., Urbano-Ispizua, A., Cavazzana-Calvo, M., Dermirer, T., Dini, G. and Einsele, H. (2006) Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Definitions and current practice in Europe. Bone Marrow Transplant, 37, pp. 439-449.
    • (2006) Bone Marrow Transplant , vol.37 , pp. 439-449
    • Ljungman, P.1    Urbano-Ispizua, A.2    Cavazzana-Calvo, M.3    Dermirer, T.4    Dini, G.5    Einsele, H.6
  • 2
    • 0027404777 scopus 로고
    • Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomised trial
    • Linch, D. C., Winfield, D., Goldstone, A. H., Moir, D., Hancock, B. and McMillan, A. (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomised trial. Lancet, 341, pp. 1051-1054.
    • (1993) Lancet , vol.341 , pp. 1051-1054
    • Linch, D.C.1    Winfield, D.2    Goldstone, A.H.3    Moir, D.4    Hancock, B.5    McMillan, A.6
  • 3
    • 0037097044 scopus 로고    scopus 로고
    • Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haematopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: A randomised trial
    • Schmitz, N., Pfistner, B., Sextro, M., Sieber, M., Carella, M. and Haenel, M. (2002) Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haematopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: A randomised trial. Lancet, 359, pp. 2065-2071.
    • (2002) Lancet , vol.359 , pp. 2065-2071
    • Schmitz, N.1    Pfistner, B.2    Sextro, M.3    Sieber, M.4    Carella, M.5    Haenel, M.6
  • 4
    • 0027954426 scopus 로고
    • Intensive therapy with cyclophosphamide, carmustine, etoposide ± cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy
    • Reece, D. E., Connors, J. M., Spinelli, J., Barnett, M. J., Fairey, R. N. and Klingermann, H. (1994) Intensive therapy with cyclophosphamide, carmustine, etoposide ± cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy. Blood, 83, pp. 1193-1199.
    • (1994) Blood , vol.83 , pp. 1193-1199
    • Reece, D.E.1    Connors, J.M.2    Spinelli, J.3    Barnett, M.J.4    Fairey, R.N.5    Klingermann, H.6
  • 5
    • 0028937428 scopus 로고
    • High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: Results in 85 patients with analysis of prognostic factors
    • Nademanee, A., O'Donnell, M. R., Snyder, D. S., Schmidt, G., Parker, P. and Stein, A. (1995) High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: Results in 85 patients with analysis of prognostic factors. Blood, 85, pp. 1381-1390.
    • (1995) Blood , vol.85 , pp. 1381-1390
    • Nademanee, A.1    O'Donnell, M.R.2    Snyder, D.S.3    Schmidt, G.4    Parker, P.5    Stein, A.6
  • 6
    • 0030942265 scopus 로고    scopus 로고
    • Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease
    • Yuen, A. R., Rosenberg, S. A., Hoppe, R. T., Halpern, J. and Horning, S. (1997) Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. Blood, 89, pp. 814-822.
    • (1997) Blood , vol.89 , pp. 814-822
    • Yuen, A.R.1    Rosenberg, S.A.2    Hoppe, R.T.3    Halpern, J.4    Horning, S.5
  • 7
    • 0027534424 scopus 로고
    • The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients
    • Chopra, R., McMillan, A. K., Linch, D. C., Yuklea, S., Taghipour, G. and Pearce, R. (1993) The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients. Blood, 81, pp. 1137-1145.
    • (1993) Blood , vol.81 , pp. 1137-1145
    • Chopra, R.1    McMillan, A.K.2    Linch, D.C.3    Yuklea, S.4    Taghipour, G.5    Pearce, R.6
  • 8
    • 17744384690 scopus 로고    scopus 로고
    • Autotransplantation for Hodgkin's disease in first relapse or second remission: A report from the Autologous Blood and Marrow Transplantation Registry (ABMTR)
    • Lazarus, H. M., Loberiza, F. R., Zhang, M. J., Armitage, J. O., Ballen, K. K. and Bashey, A. (2001) Autotransplantation for Hodgkin's disease in first relapse or second remission: A report from the Autologous Blood and Marrow Transplantation Registry (ABMTR). Bone Marrow Transplant, 27, pp. 387-396.
    • (2001) Bone Marrow Transplant , vol.27 , pp. 387-396
    • Lazarus, H.M.1    Loberiza, F.R.2    Zhang, M.J.3    Armitage, J.O.4    Ballen, K.K.5    Bashey, A.6
  • 9
    • 20944446433 scopus 로고    scopus 로고
    • Prognostic factors affecting long-term outcome after stem-cell transplantation in Hodgkin's lymphoma autografted after a first relapse
    • Sureda, A., Constans, M., Irondo, A., Arranz, R., Caballero, M. D. and Vidal, M. J. (2005) Prognostic factors affecting long-term outcome after stem-cell transplantation in Hodgkin's lymphoma autografted after a first relapse. Ann Oncol, 16, pp. 625-633.
    • (2005) Ann Oncol , vol.16 , pp. 625-633
    • Sureda, A.1    Constans, M.2    Irondo, A.3    Arranz, R.4    Caballero, M.D.5    Vidal, M.J.6
  • 10
    • 0027409446 scopus 로고
    • High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: Importance of disease status at transplant
    • Crump, M., Smith, A. M., Brandwein, J., Couture, F., Sherret, H. and Sutton, D. M. (1993) High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: Importance of disease status at transplant. J Clin Oncol, 11, p. 704.
    • (1993) J Clin Oncol , vol.11 , pp. 704
    • Crump, M.1    Smith, A.M.2    Brandwein, J.3    Couture, F.4    Sherret, H.5    Sutton, D.M.6
  • 11
    • 0027146193 scopus 로고
    • One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: Value of pretransplant disease status for predicting outcome
    • Rapoport, A. P., Rowe, J. M., Kouides, P. A., Duerst, R. A., Abboud, C. N. and Liesveld, J. L. (1993) One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: Value of pretransplant disease status for predicting outcome. J Clin Oncol, 11, pp. 2351-2361.
    • (1993) J Clin Oncol , vol.11 , pp. 2351-2361
    • Rapoport, A.P.1    Rowe, J.M.2    Kouides, P.A.3    Duerst, R.A.4    Abboud, C.N.5    Liesveld, J.L.6
  • 12
    • 0031967030 scopus 로고    scopus 로고
    • Favourable outcome of patients relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell transplantation at the time of maximal response to conventional salvage therapy (Dexa-BEAM)
    • Josting, A., Katay, I., Rueffer, U., Winter, S., Tesh, H. and Engert, A. (1998) Favourable outcome of patients relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell transplantation at the time of maximal response to conventional salvage therapy (Dexa-BEAM). Ann Oncol, 9, pp. 289-295.
    • (1998) Ann Oncol , vol.9 , pp. 289-295
    • Josting, A.1    Katay, I.2    Rueffer, U.3    Winter, S.4    Tesh, H.5    Engert, A.6
  • 13
    • 0034663188 scopus 로고    scopus 로고
    • Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: A report from the German Hodgkin Lymphoma Study Group
    • Josting, A., Rueffer, U., Franklin, J., Sieber, M., Diehl, V. and Engert, A. (2000) Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: A report from the German Hodgkin Lymphoma Study Group. Blood, 96, pp. 1280-1286.
    • (2000) Blood , vol.96 , pp. 1280-1286
    • Josting, A.1    Rueffer, U.2    Franklin, J.3    Sieber, M.4    Diehl, V.5    Engert, A.6
  • 14
    • 2942536855 scopus 로고    scopus 로고
    • Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma
    • Popat, U., Hosing, C., Saliba, R. M., Anderlini, P., van Besien, K. and Przepiorka, D. (2004) Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma. Bone Marrow Transplant, 33, pp. 1015-1023.
    • (2004) Bone Marrow Transplant , vol.33 , pp. 1015-1023
    • Popat, U.1    Hosing, C.2    Saliba, R.M.3    Anderlini, P.4    van Besien, K.5    Przepiorka, D.6
  • 15
    • 0036737680 scopus 로고    scopus 로고
    • The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation
    • Bierman, P. J., Lynch, J. C., Bociek, R. G., Whalen, V. L., Kessinger, A. and Vose, J. M. (2002) The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation. Ann Oncol, 13, pp. 1370-1377.
    • (2002) Ann Oncol , vol.13 , pp. 1370-1377
    • Bierman, P.J.1    Lynch, J.C.2    Bociek, R.G.3    Whalen, V.L.4    Kessinger, A.5    Vose, J.M.6
  • 16
    • 0035281922 scopus 로고    scopus 로고
    • Autologous stem-cell transplantation for Hodgkin's disease: Results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea Spanish Cooperative Group
    • Sureda, A., Arranz, R., Iriondo, A., Carreras, E., Lahuerta, J. J. and García-Conde, J. (2001) Autologous stem-cell transplantation for Hodgkin's disease: Results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea Spanish Cooperative Group. J Clin Oncol, 19, pp. 1395-1404.
    • (2001) J Clin Oncol , vol.19 , pp. 1395-1404
    • Sureda, A.1    Arranz, R.2    Iriondo, A.3    Carreras, E.4    Lahuerta, J.J.5    García-Conde, J.6
  • 17
    • 0032887877 scopus 로고    scopus 로고
    • High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: Results in 175 patients reported to the European Group for Blood and Marrow Transplantation
    • Sweetenham, J., Carella, A., Taghipour, G., Cunningham, D., Marcus, R. and Della Volpe, A. (1999) High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: Results in 175 patients reported to the European Group for Blood and Marrow Transplantation. J Clin Oncol, 17, pp. 3101-3109.
    • (1999) J Clin Oncol , vol.17 , pp. 3101-3109
    • Sweetenham, J.1    Carella, A.2    Taghipour, G.3    Cunningham, D.4    Marcus, R.5    Della Volpe, A.6
  • 18
    • 0033008436 scopus 로고    scopus 로고
    • Autotransplants for Hodgkin's disease in patients never achieving remission: A report from the Autologous Blood and Marrow Transplantation Registry (ABMTR)
    • Lazarus, H. M., Rowlings, P. A., Zhang, M. J., Vose, J. M., Armitage, J. and Bierman, P. (1999) Autotransplants for Hodgkin's disease in patients never achieving remission: A report from the Autologous Blood and Marrow Transplantation Registry (ABMTR). J Clin Oncol, 17, pp. 534-545.
    • (1999) J Clin Oncol , vol.17 , pp. 534-545
    • Lazarus, H.M.1    Rowlings, P.A.2    Zhang, M.J.3    Vose, J.M.4    Armitage, J.5    Bierman, P.6
  • 19
    • 0037767208 scopus 로고    scopus 로고
    • Autologous stem cell transplantation for primary refractory Hodgkin's disease: Results and clinical variables affecting outcome
    • Constans, M., Sureda, A., Terol, M. J., Arranz, R., Caballero, M. D. and Irondo, A. (2003) Autologous stem cell transplantation for primary refractory Hodgkin's disease: Results and clinical variables affecting outcome. Ann Oncol, 14, pp. 745-751.
    • (2003) Ann Oncol , vol.14 , pp. 745-751
    • Constans, M.1    Sureda, A.2    Terol, M.J.3    Arranz, R.4    Caballero, M.D.5    Irondo, A.6
  • 20
    • 0037080278 scopus 로고    scopus 로고
    • Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: Results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial
    • Fermé, C., Mournier, N., Diviné M., Brice, P., Stamatoullas, A. and Reman, O. (2002) Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: Results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial. J Clin Oncol, 20, pp. 467-475.
    • (2002) J Clin Oncol , vol.20 , pp. 467-475
    • Fermé, C.1    Mournier, N.2    Diviné, M.3    Brice, P.4    Stamatoullas, A.5    Reman, O.6
  • 21
    • 0032548107 scopus 로고    scopus 로고
    • A prognostic score for advanced Hodgkin's disease
    • Hasenclever, D. and Diehl, V. (1998) A prognostic score for advanced Hodgkin's disease. N Eng J Med, 339, pp. 1506-1514.
    • (1998) N Eng J Med , vol.339 , pp. 1506-1514
    • Hasenclever, D.1    Diehl, V.2
  • 22
    • 0030938978 scopus 로고    scopus 로고
    • High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: Analysis of the Stanford University results and prognostic indices
    • Horning, S. J., Chao, N. J., Negrin, R. S., Hoppe, R. and Long, G. (1997) High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: Analysis of the Stanford University results and prognostic indices. Blood, 89, pp. 801-813.
    • (1997) Blood , vol.89 , pp. 801-813
    • Horning, S.J.1    Chao, N.J.2    Negrin, R.S.3    Hoppe, R.4    Long, G.5
  • 24
    • 0033955726 scopus 로고    scopus 로고
    • Clinical relevance of 67-gallium scintigraphy in lymphoma before and after chemotherapy
    • Delcambre, C., Reman, O., Henry-Amar, M., Peny, Am, Macro, M. and Cheze, S. (2000) Clinical relevance of 67-gallium scintigraphy in lymphoma before and after chemotherapy. Eur J Nucl Med, 27, pp. 176-184.
    • (2000) Eur J Nucl Med , vol.27 , pp. 176-184
    • Delcambre, C.1    Reman, O.2    Henry-Amar, M.3    Peny Am Macro, M.4    Cheze, S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.